Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-Aquaporin-4 Antibody Positivity in Neuromyelitis Optica Is Associated with Lesion Activity.
Infodemiology and infoveillance of multiple sclerosis in Italy.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Current and Future Therapies for Multiple Sclerosis.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification.
Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Brain Perfusion and Vasoreactivity in Multiple Sclerosis.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Validity and Reliability of the Persian Version of the PERception de la Scle'rose En Plaques et de ses Pousse'es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life.
Oropharyngeal dysphagia in multiple sclerosis.
What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
[Clinical course and prognosis of multiple sclerosis].
B Cells Fuel Inflammation in Multiple Sclerosis.
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
Bayesian scalar-on-image regression with application to association between intracranial DTI and cognitive outcomes.
Emerging injectable therapies for multiple sclerosis.
Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Randomized trial of erhuangfang for relapsing multiple sclerosis.
Elderly-onset neuromyelitis optica spectrum disorders.
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.
Pages
« first
‹ previous
…
655
656
657
658
659
660
661
662
663
…
next ›
last »